Section Arrow
SGHT.NASDAQ
- Sight Sciences
Quotes are at least 15-min delayed:2025/02/01 12:02 EST
Last
 2.8
-0.17 (-5.72%)
Day High 
2.98 
Prev. Close
2.97 
1-M High
3.73 
Volume 
154.97K 
Bid
2.8
Ask
3.06
Day Low
2.77 
Open
2.96 
1-M Low
2.675 
Market Cap 
149.68M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.94 
20-SMA 3.14 
50-SMA 3.51 
52-W High 8.45 
52-W Low 2.675 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.01/-0.48
Enterprise Value
182.30M
Balance Sheet
Book Value Per Share
1.88
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
23.35M
Operating Revenue Per Share
1.64
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SENSSenseonics Holdings0.9608-0.1292-11.85%-- 
QSIQuantum-Si1.98+0.02+1.02%-- 
PACBPacific Biosciences of California1.54-0.06-3.75%-- 
MDTMedtronic plc90.82-1.17-1.27%28.13PE
ABTAbbott Laboratories127.93-0.88-0.68%39.2PE
Quotes are at least 15-min delayed:2025/02/01 12:02 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.